Article info

Original research
Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse model of multiple myeloma through activation of CD8 T cells against non-vaccine, tumor-associated antigens

Authors

  1. Correspondence to Dr Selma Bekri; selma.bekri{at}mssm.edu
View Full Text

Citation

Bekri S, Rodney-Sandy R, Gruenstein D, et al
Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse model of multiple myeloma through activation of CD8 T cells against non-vaccine, tumor-associated antigens

Publication history

  • Accepted January 11, 2022
  • First published February 21, 2022.
Online issue publication 
February 21, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.